Lopez Carlos Luis
SEC insider (Form 3/4/5 filer). CIK 0002042509. SVP, General Counsel at Niagen Bioscience, Inc. (NAGE). 4 reported Form 4/5 transactions since Sep 2024; latest on Jun 30, 2026. Located in LOS ANGELES, CA.
Companies Lopez Carlos Luis has filed insider reports for
- Niagen Bioscience, Inc. (NAGE): Officer, SVP, General Counsel
Lopez Carlos Luis
CIK: 0002042509
Transaction Breakdown
Open Market Buys (P)1 (25.0%)
High conviction signal
Open Market Sales (S)0 (0.0%)
Position reduction
Option Exercises (M)0 (0.0%)
Derivative conversions
Awards (A)3 (75.0%)
Compensation grants
Other (G, F, J, C, D, …)0 (0.0%)
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
NAGE
Niagen Bioscience, Inc.
Officer
Discretionary Trading P&L
Holdings
Transaction History (4 total)
- Jun 30, 2026NAGE
Niagen Bioscience, Inc.
AwardDirect2.3K shares at avg. $2.71$6K - Feb 19, 2026NAGE
Niagen Bioscience, Inc.
AwardDirectEmployee Stock Options (right to buy)
41.4K shares- - Mar 7, 2025CDXC
ChromaDex Corp.
PurchaseDirect273 shares at avg. $7.86$2K - Feb 12, 2025CDXC
ChromaDex Corp.
AwardDirectEmployee Stock Options (right to buy)
19.7K shares-
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Jun 30, 2026 | NAGE Niagen Bioscience, Inc. | Award | 2,314 | $2.71 | $6,271 | Direct |
| Feb 19, 2026 | NAGE Niagen Bioscience, Inc. | Award Employee Stock Options (right to buy) | 41,420 | - | - | Direct |
| Mar 7, 2025 |  CDXC ChromaDex Corp. | Purchase | 273 | $7.86 | $2,146 | Direct |
| Feb 12, 2025 | CDXC ChromaDex Corp. | Award Employee Stock Options (right to buy) | 19,691 | - | - | Direct |
1-4 of 4 transactions